Last Updated

24 Jan 2019

From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade

Click on the image above to open the resource:

From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade

"From Pipeline to Product: Malaria R&D funding needs into the next decade" serves as a tool to guide policymakers’ investment in new tools to control malaria, contain emerging threats, and move toward the goal of eradicating malaria from the world. It looks at the estimated funding needed for R&D of new malaria tools until 2022, including for basic research, drugs, vaccines, diagnostics, and vector control agents. The report provides an update to the 2011 Staying the Course report, which estimated R&D cost and R&D investments for all malaria R&D activities.

Author(s)

Collaborator(s)

FIND
IVCC, UK
Medicines for Malaria Venture (MMV)
PATH Malaria Vaccine Initiative (MVI)

Date Published